DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 46 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2016$3,170,000
-68.6%
1,315,5510.0%0.14%
-67.0%
Q4 2015$10,090,000
+45.0%
1,315,5510.0%0.41%
+52.0%
Q3 2015$6,959,000
-41.0%
1,315,5510.0%0.27%
-31.6%
Q2 2015$11,800,000
+36.8%
1,315,551
-3.6%
0.39%
+40.9%
Q1 2015$8,627,000
+239.0%
1,365,000
+458.2%
0.28%
+168.3%
Q1 2014$2,545,000244,5240.10%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 392,952$4,051,0000.53%
BLUESTEIN R H & CO LLC 179,800$1,854,0000.12%
Edge Wealth Management LLC 15,000$154,0000.07%
Tower Research Capital LLC (TRC) 1,316$14,0000.00%
VANGUARD GROUP INC 37,190$384,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 100$1,0000.00%
UBS AG 1,878$19,0000.00%
BANK OF AMERICA CORP /DE/ 106$1,0000.00%
FIRST MANHATTAN CO. LLC. 2,500$25,0000.00%
CREDIT SUISSE AG/ 19,370$200,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders